Home/Filings/4/0001127602-13-013305
4//SEC Filing

DODION PIERRE F 4

Accession 0001127602-13-013305

CIK 0000884731other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:52 PM ET

Size

8.3 KB

Accession

0001127602-13-013305

Insider Transaction Report

Form 4
Period: 2013-04-01
DODION PIERRE F
Senior VP, Chief Medical Off
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2013-04-016,0000 total
    Common Stock (6,000 underlying)
  • Exercise/Conversion

    Common Stock

    2013-04-01+6,00060,082 total
  • Sale

    Common Stock

    2013-04-02$18.04/sh2,400$43,29557,682 total
Footnotes (4)
  • [F1]Shares were acquired upon vesting of restricted stock units awarded on April 1, 2011.
  • [F2]Represents shares withheld to satisfy withholding tax requirements.
  • [F3]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
  • [F4]The restricted stock units vested on April 1, 2013.

Issuer

ARIAD PHARMACEUTICALS INC

CIK 0000884731

Entity typeother

Related Parties

1
  • filerCIK 0001403174

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:52 PM ET
Size
8.3 KB